GL Pharm Tech Corp
204840
Company Profile
Business description
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. The company possesses platform formulation technology for drug sustained release, solubilization, stabilization, and enhanced absorption in the colon.
Contact
46 Dalraenae-ro
Seongnam Global Convergence Center B-210
Gyeonggi-do
Sujeong-gu
Seongnam462713
KORT: +82 317395220
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
34
Stocks News & Analysis
stocks
ASX healthcare giant remains well positioned despite share slump
We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks
Australian bank remains overvalued despite strong result
When strong fundamentals meet persistent valuation headwinds.
stocks
Chart of the Week: Soft earnings growth outlook for Australian banks
The latest take from our equity research analysts.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,281.80 | 41.30 | -0.44% |
| CAC 40 | 8,387.54 | 74.30 | 0.89% |
| DAX 40 | 25,191.96 | 335.81 | 1.35% |
| Dow JONES (US) | 50,121.40 | 66.74 | -0.13% |
| FTSE 100 | 10,487.65 | 15.54 | 0.15% |
| HKSE | 27,032.54 | 233.84 | -0.86% |
| NASDAQ | 23,066.47 | 36.01 | -0.16% |
| Nikkei 225 | 57,639.84 | 10.70 | -0.02% |
| NZX 50 Index | 13,531.48 | 24.20 | 0.18% |
| S&P 500 | 6,941.47 | 0.34 | -0.00% |
| S&P/ASX 200 | 9,043.50 | 18.50 | -0.20% |
| SSE Composite Index | 4,134.02 | 2.03 | 0.05% |